Zobrazeno 1 - 10 of 887 pro vyhledávání: '"S, Aschenbrenner"'
1
Akademický článek
Holocene surface-rupturing earthquakes on the Dinaric Fault System, western Slovenia
Autor: C. Grützner, S. Aschenbrenner, P. Jamšek Rupnik, K. Reicherter, N. Saifelislam, B. Vičič, M. Vrabec, J. Welte, K. Ustaszewski
Publikováno v: Solid Earth, Vol 12, Pp 2211-2234 (2021)
The Dinaric Fault System in western Slovenia, consisting of NW–SE-trending, right-lateral strike-slip faults, accommodates the northward motion of Adria with respect to Eurasia. These active faults show a clear imprint in the morphology, and some o
Externí odkaz: https://doaj.org/article/8f5ff0abf834477e98079cf15796bd6f
Zobrazit plný text záznamu
2
Cognition and driving ability in chronic pain syndrome
Autor: J. Schmidt, M. Weisbrod, M. Fritz, S. Aschenbrenner
Publikováno v: Der Nervenarzt. 94:335-343
ZusammenfassungKognitive Auffälligkeiten bei Patienten mit chronischen Schmerzen finden in wissenschaftlichen Untersuchungen zunehmend Beachtung. Die Folgen dieser kognitiven Störungen in Bezug auf die Schmerzbewältigung, die Alltagsgestaltung und
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::65c61d057f9f8ae527bedf6e6e9c1658
https://doi.org/10.1007/s00115-022-01387-y
Zobrazit plný text záznamu
4
New Drug Approved For ALS
Autor: Diane S. Aschenbrenner
Publikováno v: The American journal of nursing. 123(1)
Sodium phenylbutyrate-taurursodiol (Relyvrio) has been approved to treat amyotrophic lateral sclerosis.The drug was approved despite the absence of phase 3 clinical trial data. Data from a small phase 2 trial indicated that patients receiving Relyvri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed047780860168366ffa240ef2fef18
https://pubmed.ncbi.nlm.nih.gov/36546382
Zobrazit plný text záznamu
7
Drug Receives New Indication for Pediatric Graft-Versus-Host Disease
Autor: Diane S. Aschenbrenner
Publikováno v: The American journal of nursing. 122(12)
Ibrutinib (Imbruvica) has received a new indication for the treatment of graft-versus-host disease in pediatric patients at least one year of age when one or more systemic therapies have failed.The product's labeling warns of the risk of hemorrhage,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d316a0d64ee320ace7fef30dcccbb1e
https://pubmed.ncbi.nlm.nih.gov/36384792
Zobrazit plný text záznamu
8
Two New Drugs Approved for Non-Small Cell Lung Cancer
Autor: Diane S. Aschenbrenner
Publikováno v: The American journal of nursingREFERENCE. 122(12)
The Food and Drug Administration (FDA) has approved capmatinib (Tabrecta) for the treatment of metastatic non-small cell lung cancer in adults whose tumors have a mutation leading to mesenchymal-epithelial transition exon 14 skipping.Nurses should mo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f20902ec8ace7a981f4d38d2fdd9d97
https://pubmed.ncbi.nlm.nih.gov/36384791
Zobrazit plný text záznamu
9
New Indication for Topical Ruxolitnib
Autor: Diane S. Aschenbrenner
Publikováno v: The American journal of nursing. 122(11)
The Food and Drug Administration has approved the Janus kinase inhibitor ruxolitnib (Opzelura) as topical treatment for nonsegmental vitiligo in children and adults ages 12 years and older.The most common adverse effects are application site acne, ap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d05f1981fc4efde03ea304610e7f5922
https://pubmed.ncbi.nlm.nih.gov/36261902
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje